MedCity News | How the IRA Has Created a New Environment for Biosimilars
By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…
CertaraJanuary 5, 2024
Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024
By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…
CertaraJanuary 5, 2024
Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024
By Bio-IT World Team To kick off the New Year, we spoke with leaders and…
CertaraJanuary 5, 2024
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations
This mini-review provides a concise and comprehensive overview of the pregnancy PBPK field and identify…
CertaraJanuary 3, 2024
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
This comprehensive review exposes gaps in current knowledge of phase II enzyme and drug transporter…
CertaraJanuary 3, 2024
Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
For drugs highly bound to plasma proteins, changes in concentrations of free drug may have…
CertaraJanuary 3, 2024
Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions
Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP…
CertaraJanuary 2, 2024
Modeling and simulation in pediatric drug development
Published: December 21, 2023 This is the article written in German, published on pharmind. Children's…
CertaraDecember 21, 2023
Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials
A FRIENDS OF CANCER RESEARCH WHITE PAPER The article explores the complex landscape of determining…
CertaraDecember 19, 2023
